What is equivalent to Bydureon? Understanding Alternatives After Discontinuation
•
5 min read
In late 2024, pharmaceutical company AstraZeneca discontinued Bydureon and Bydureon BCise, leaving many patients who relied on the once-weekly injection to seek new options. While there is no direct generic for the drug, known by its active ingredient extended-release exenatide, several other medications within the same class offer similar therapeutic benefits. Understanding **what is equivalent to Bydureon** is now essential for making a smooth and effective transition with a healthcare provider.
